147 related articles for article (PubMed ID: 10081512)
1. Determinants of the natural history of human immunodeficiency virus type 1 infection.
Phair JP
J Infect Dis; 1999 Mar; 179 Suppl 2():S384-6. PubMed ID: 10081512
[TBL] [Abstract][Full Text] [Related]
2. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
Furrer H; Barloggio A; Egger M; Garweg JG;
Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
[TBL] [Abstract][Full Text] [Related]
3. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
5. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
Blattner WA; Oursler KA; Cleghorn F; Charurat M; Sill A; Bartholomew C; Jack N; O'Brien T; Edwards J; Tomaras G; Weinhold K; Greenberg M
J Infect Dis; 2004 May; 189(10):1793-801. PubMed ID: 15122515
[TBL] [Abstract][Full Text] [Related]
6. AIDS pathogenesis: from models to viral dynamics in patients.
Nowak MA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S1-5. PubMed ID: 8595501
[TBL] [Abstract][Full Text] [Related]
7. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
Barbour JD; Hecht FM; Wrin T; Segal MR; Ramstead CA; Liegler TJ; Busch MP; Petropoulos CJ; Hellmann NS; Kahn JO; Grant RM
J Infect Dis; 2004 Jul; 190(2):251-6. PubMed ID: 15216458
[TBL] [Abstract][Full Text] [Related]
8. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
[TBL] [Abstract][Full Text] [Related]
9. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.
Fuller JD; Craven DE; Steger KA; Cox N; Heeren TC; Chernoff D
Clin Infect Dis; 1999 Mar; 28(3):541-7. PubMed ID: 10194075
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and natural history of HIV infection.
Sleasman JW; Goodenow MM
J Fla Med Assoc; 1991 Oct; 78(10):678-81. PubMed ID: 1753233
[TBL] [Abstract][Full Text] [Related]
12. [HIV controllers: a homogeneous group of HIV-1 infected patients with a spontaneous control of viral replication].
Lambotte O; Delfraissy JF
Pathol Biol (Paris); 2006 Dec; 54(10):566-71. PubMed ID: 17027185
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.
Wit FW; van Rij RP; Weverling GJ; Lange JM; Schuitemaker H
J Infect Dis; 2002 Dec; 186(12):1726-32. PubMed ID: 12447757
[TBL] [Abstract][Full Text] [Related]
14. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors.
Alexander L; Cuchura L; Simpson BJ; Andiman WA
Pediatr Infect Dis J; 2006 Feb; 25(2):135-41. PubMed ID: 16462290
[TBL] [Abstract][Full Text] [Related]
17. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis.
Fantuzzi L; Belardelli F; Gessani S
J Leukoc Biol; 2003 Nov; 74(5):719-25. PubMed ID: 12960239
[TBL] [Abstract][Full Text] [Related]
18. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
[TBL] [Abstract][Full Text] [Related]
19. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
Sterling TR; Hoover DR; Astemborski J; Vlahov D; Bartlett JG; Schupbach J
J Infect Dis; 2002 Oct; 186(8):1181-5. PubMed ID: 12355373
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
